BostonGene and Exigent Genomic INsight Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBostonGene
About this trial
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
Eligibility criteria
Qualifiers
Life expectancy > 3 months as per the treating physician
Willingness to provide informed consent
Living in the United States at time of enrollment
Agree to participate in genomic and molecular profiling
Disqualifiers
not meeting the inclusion criteria
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 4 trial groupsSponsors and collaborators
BostonGene
Lead sponsor
Exigent
Collaborator
Source ClinicalTrials.gov